Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents

Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents

US Patent 5536749 · Granted Jul 16, 1996

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Amelioration of the development of cataracts and other ophthalmic diseases2013
Amelioration of the development of cataracts and other ophthalmic diseases2013
Amelioration of cataracts, macular degeneration and other ophthalmic diseases2010
Amelioration of cataracts, macular degeneration and other ophthalmic diseases2010
Oculoselective drugs and prodrugs2010
Oculoselective drugs and prodrugs2010
Amelioration of vitrectomy-induced cataracts2009
Amelioration of vitrectomy-induced cataracts2009
Amelioration of the development of cataracts and other ophthalmic diseases2008
Amelioration of the development of cataracts and other ophthalmic diseases2008
Phenylpropionic acids and esters: compounds and methods for inducing beta-blocka2001
Polyhydroxybenzyloxpropanolamines1991